Vaccine makers in the Asia-Pacific (APAC) region are keen to ramp up capacities for mRNA technology, according to a study sponsored by Merck. With the range of tools we offer, we can better equip vaccine manufacturers to treat the regional and global population,” she said. Merck’s Life Science business supports mRNA manufacturers to accelerate speed to market, and in turn the delivery of mRNA vaccines to patients worldwide. Aditya Sharma, Head – Bioprocessing, Merck Life Science India, added, “India is exploring mRNA vaccines and is focused on developing its own mRNA vaccine in partnership with global organisations. India’s diverse pharmaceutical industry and large population offer opportunities for the production of mRNA vaccines.

Source: The Hindu June 01, 2023 12:46 UTC